1. Home
  2. ACOG vs ECBK Comparison

ACOG vs ECBK Comparison

Compare ACOG & ECBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • ECBK
  • Stock Information
  • Founded
  • ACOG 2000
  • ECBK 1919
  • Country
  • ACOG Canada
  • ECBK United States
  • Employees
  • ACOG N/A
  • ECBK N/A
  • Industry
  • ACOG
  • ECBK Banks
  • Sector
  • ACOG
  • ECBK Finance
  • Exchange
  • ACOG Nasdaq
  • ECBK Nasdaq
  • Market Cap
  • ACOG 130.9M
  • ECBK 153.5M
  • IPO Year
  • ACOG N/A
  • ECBK N/A
  • Fundamental
  • Price
  • ACOG $6.18
  • ECBK $17.37
  • Analyst Decision
  • ACOG Strong Buy
  • ECBK
  • Analyst Count
  • ACOG 1
  • ECBK 0
  • Target Price
  • ACOG $18.00
  • ECBK N/A
  • AVG Volume (30 Days)
  • ACOG 110.9K
  • ECBK 8.9K
  • Earning Date
  • ACOG 11-13-2025
  • ECBK 10-22-2025
  • Dividend Yield
  • ACOG N/A
  • ECBK N/A
  • EPS Growth
  • ACOG N/A
  • ECBK 104.95
  • EPS
  • ACOG N/A
  • ECBK 0.80
  • Revenue
  • ACOG $7,427,199.00
  • ECBK $29,860,000.00
  • Revenue This Year
  • ACOG N/A
  • ECBK N/A
  • Revenue Next Year
  • ACOG $101.16
  • ECBK N/A
  • P/E Ratio
  • ACOG N/A
  • ECBK $21.69
  • Revenue Growth
  • ACOG N/A
  • ECBK 20.84
  • 52 Week Low
  • ACOG $3.75
  • ECBK $12.56
  • 52 Week High
  • ACOG $11.54
  • ECBK $17.75
  • Technical
  • Relative Strength Index (RSI)
  • ACOG 47.49
  • ECBK 60.70
  • Support Level
  • ACOG $5.66
  • ECBK $16.84
  • Resistance Level
  • ACOG $6.33
  • ECBK $17.55
  • Average True Range (ATR)
  • ACOG 0.54
  • ECBK 0.31
  • MACD
  • ACOG 0.07
  • ECBK -0.02
  • Stochastic Oscillator
  • ACOG 73.52
  • ECBK 58.10

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About ECBK ECB Bancorp Inc.

ECB Bancorp Inc operates as a bank holding company of Everett Co-operative Bank. The firm through its subsidiary engages in business consisting of taking deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential real estate loans, commercial real estate, and multifamily real estate loans, construction and land loans and home equity lines of credit.

Share on Social Networks: